CVS SEC filings (2026)
CIK 64803 · Retail-Drug Stores and Proprietary Stores (SIC 5912) · incorporated in DE · fiscal year ends in December
2,968 filings on EDGAR since 1994 · 35 annual, 102 quarterly, 391 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
August 2026
- Aug 178-K8-K · CVS Health Announces Board ChangesDirectors or officers; compensation; Regulation FD disclosure
- Aug 5EarningsEarnings release — EPS $2.58 vs $1.87 est. (+38.0%); revenue $106.10B (+7% y/y) 5.1%
- Aug 5ReportQuarterly report, Q2 2026 — revenue $106.10B (+7% y/y), net income $2.98B, EPS $2.31
May 2026
- May 21Insider saleROBBINS LARRY (Director) sold 378,000 shares for $35.3M at $93.31
- May 21Insider saleROBBINS LARRY (Director) sold 370,462 shares for $34.6M at $93.45
- May 20Insider saleROBBINS LARRY (Director) sold 1,018,000 shares for $95.5M at $93.48–$96.28
- May 19Insider saleROBBINS LARRY (Director) sold 1,983,538 shares for $187.3M at $94.45–$95.18
- May 188-K8-K · Directors or officers; compensation; Shareholder vote results
- May 8Insider saleMandadi Tilak (EVP, Chief Exp & Tech Officer) sold 69,551 shares for $6.2M at $89.58
- May 6EarningsEarnings release — EPS $2.57 vs $2.21 est. (+16.3%); revenue $100.43B (+6% y/y) 7.6%
- May 6ReportQuarterly report, Q1 2026 — revenue $100.43B (+6% y/y), net income $2.94B, EPS $2.30
April 2026
- Apr 3ProxyProxy · Annual report to shareholders
- Apr 3ProxyProxy · Additional proxy materials
- Apr 3ProxyProxy · Proxy statement
March 2026
- Mar 198-K8-K · Directors or officers; compensation
February 2026
December 2025
- Dec 98-K8-K · CVS Health Updates Financial Guidance, Highlights Strength of Businesses, and Announces Strategy to Uniquely Reimagine Health Care at Investor Day EventRegulation FD disclosure
November 2025
- Nov 208-K8-K · Other events
October 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $359.0M in 5 sales and bought $1,289 in 1 purchase; 45 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| May 21, 2026Form 4 | ROBBINS LARRYDirectorSold · $35.3M · 378,000 sh |
| May 21, 2026Form 4 | ROBBINS LARRYDirectorSold · $34.6M · 370,462 sh |
| May 20, 2026Form 4 | ROBBINS LARRYDirectorSold · $95.5M · 1,018,000 sh |
| May 19, 2026Form 4 | ROBBINS LARRYDirectorSold · $187.3M · 1,983,538 sh |
| May 8, 2026Form 4 | Mandadi TilakEVP, Chief Exp & Tech OfficerSold · $6.2M · 69,551 sh |
| Jan 23, 2025Form 4 | Nelson Steven HEVP and President, AetnaBought · $1,289 · 24 sh |
Awards, exercises, withholding and plan purchases · 45 transactions
| Date | Insider |
|---|---|
| Jun 26, 2026Form 4 | Clark James DavidSVP, Cont & Chief Acct OfficerTax withholding · $41K · 454 sh |
| May 31, 2026Form 4 | Compton-Phillips AmyEVP, Chief Medical OfficerTax withholding · $693K · 7,618 sh |
| May 31, 2026Form 4 | Newman BrianEVP, Chief Financial OfficerTax withholding · $225K · 2,478 sh |
| May 21, 2026Form 4 | AGUIRRE FERNANDODirectorOther · $146K · 1,563 sh |
| May 20, 2026Form 4 | AGUIRRE FERNANDODirectorOther · $2.9M · 30,437 sh |
| May 14, 2026Form 4 | Balser Jeffrey R.DirectorAward · $200K · 2,058 sh |
| May 14, 2026Form 4 | ROBBINS LARRYDirectorAward · Deferred Stock Units · $187K · 1,930.005 sh |
| May 14, 2026Form 4 | Mahoney Michael FDirectorAward · Deferred Stock Units · $169K · 1,737.005 sh |
| May 14, 2026Form 4 | AGUIRRE FERNANDODirectorAward · $152K · 1,563 sh |
| May 14, 2026Form 4 | Finucane Anne A.DirectorAward · Deferred Stock Units · $150K · 1,544.004 sh |
| May 14, 2026Form 4 | BROWN C DAVID IIDirectorAward · $150K · 1,544 sh |
| May 14, 2026Form 4 | Shulman Douglas H.DirectorAward · Deferred Stock Units · $141K · 1,447.504 sh |
| May 14, 2026Form 4 | DECOUDREAUX ALECIA ADirectorAward · Deferred Stock Units · $141K · 1,447.504 sh |
| May 14, 2026Form 4 | Gallina John EDirectorAward · Deferred Stock Units · $141K · 1,447.504 sh |
| May 14, 2026Form 4 | SANSONE GUY PDirectorAward · $141K · 1,447 sh |
| May 14, 2026Form 4 | Norwalk Leslie VDirectorAward · $141K · 1,447 sh |
| May 14, 2026Form 4 | KIRBY J SCOTTDirectorAward · $141K · 1,447 sh |
| Apr 1, 2026Form 4 | Joyner J. DavidPresident, CEO and Chair · DirectorTax withholding · $582K · 8,029 sh |
| Apr 1, 2026Form 4 | Mandadi TilakEVP, Chief Exp & Tech OfficerTax withholding · $263K · 3,634 sh |
| Apr 1, 2026Form 4 | Khichi Samrat S.EVP, CPO and General CounselTax withholding · $257K · 3,541 sh |
| Apr 1, 2026Form 4 | Clark James DavidSVP, Cont & Chief Acct OfficerTax withholding · $236K · 3,262 sh |
| Apr 1, 2026Form 4 | Nelson Steven HEVP and President, AetnaTax withholding · $176K · 2,432 sh |
| Apr 1, 2026Form 4 | Shah Prem SEVP and Group PresidentTax withholding · $108K · 1,484 sh |
| Apr 1, 2026Form 4 | CAPOZZI HEIDI BEVP and Chief People OfficerTax withholding · $97K · 1,334 sh |
| Mar 31, 2026Form 4 | Shah Prem SEVP and Group PresidentAward · Stock Option · $11.6M · 161,676 sh |
| Mar 31, 2026Form 4 | Mandadi TilakEVP, Chief Exp & Tech OfficerAward · Stock Option · $10.3M · 143,712 sh |
| Mar 31, 2026Form 4 | Nelson Steven HEVP and President, AetnaAward · Stock Option · $10.3M · 143,712 sh |
| Mar 31, 2026Form 4 | Newman BrianEVP, Chief Financial OfficerAward · Stock Option · $9.0M · 125,748 sh |
| Mar 31, 2026Form 4 | Joyner J. DavidPresident, CEO and Chair · DirectorAward · Common Stock (RSUs) · $6.2M · 86,326 sh |
| Mar 31, 2026Form 4 | Khichi Samrat S.EVP, CPO and General CounselAward · Stock Option · $5.8M · 80,838 sh |
| Mar 31, 2026Form 4 | CAPOZZI HEIDI BEVP and Chief People OfficerAward · Stock Option · $4.6M · 64,670 sh |
| Mar 31, 2026Form 4 | Compton-Phillips AmyEVP, Chief Medical OfficerAward · Stock Option · $2.6M · 35,928 sh |
| Mar 31, 2026Form 4 | Shah Prem SEVP and Group PresidentAward · $1.8M · 25,062 sh |
| Mar 31, 2026Form 4 | Mandadi TilakEVP, Chief Exp & Tech OfficerAward · Common Stock (RSUs) · $1.6M · 22,277 sh |
| Mar 31, 2026Form 4 | Nelson Steven HEVP and President, AetnaAward · $1.6M · 22,277 sh |
| Mar 31, 2026Form 4 | Newman BrianEVP, Chief Financial OfficerAward · Common Stock (RSUs) · $1.4M · 19,493 sh |
| Mar 31, 2026Form 4 | Khichi Samrat S.EVP, CPO and General CounselAward · $900K · 12,531 sh |
| Mar 31, 2026Form 4 | Clark James DavidSVP, Cont & Chief Acct OfficerAward · Stock Option · $860K · 11,976 sh |
| Mar 31, 2026Form 4 | Clark James DavidSVP, Cont & Chief Acct OfficerAward · $800K · 11,138 sh |
| Mar 31, 2026Form 4 | CAPOZZI HEIDI BEVP and Chief People OfficerAward · $720K · 10,025 sh |
| Mar 31, 2026Form 4 | Compton-Phillips AmyEVP, Chief Medical OfficerAward · Common Stock (RSUs) · $400K · 5,569 sh |
| Mar 19, 2026Form 4 | Gallina John EDirectorAward · $42K · 582 sh |
| Feb 28, 2026Form 4 | Khichi Samrat S.EVP, CPO and General CounselTax withholding · $628K · 7,886 sh |
| Feb 28, 2026Form 4 | Joyner J. DavidPresident and CEO · DirectorTax withholding · $155K · 1,944 sh |
| Jan 1, 2026Form 4 | Shah Prem SEVP and Group PresidentTax withholding · $20K · 247 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 12 filings
| Filed | What it is |
|---|---|
| Aug 17, 20268-K | CVS Health Announces Board ChangesDirectors or officers; compensation; Regulation FD disclosure |
| Aug 5, 202610-Q | Quarterly report, Q2 2026 — revenue $106.10B (+7% y/y), net income $2.98B, EPS $2.31 |
| Aug 5, 20268-K | Earnings release — EPS $2.58 vs $1.87 est. (+38.0%); revenue $106.10B (+7% y/y) 5.1% |
| May 18, 20268-K | Directors or officers; compensation; Shareholder vote results |
| May 6, 202610-Q | Quarterly report, Q1 2026 — revenue $100.43B (+6% y/y), net income $2.94B, EPS $2.30 |
| May 6, 20268-K | Earnings release — EPS $2.57 vs $2.21 est. (+16.3%); revenue $100.43B (+6% y/y) 7.6% |
| Apr 3, 2026ARS | Annual report to shareholders |
| Apr 3, 2026DEFA14A | Additional proxy materials |
| Apr 3, 2026DEF 14A | Proxy statement |
| Mar 19, 20268-K | Directors or officers; compensation |
| Feb 10, 202610-K | Annual report, FY2025 — revenue $402.07B (+8% y/y), net income $1.77B, EPS $1.39 |
| Feb 10, 20268-K | Earnings release — EPS $1.09 vs $0.99 est. (+10.1%); revenue $105.69B (+8% y/y) 0.1% |
2025 · 17 filings
| Filed | What it is |
|---|---|
| Dec 9, 20258-K | CVS Health Updates Financial Guidance, Highlights Strength of Businesses, and Announces Strategy to Uniquely Reimagine Health Care at Investor Day EventRegulation FD disclosure |
| Nov 20, 20258-K | Other events |
| Oct 29, 202510-Q | Quarterly report, Q3 2025 — revenue $102.87B (+8% y/y), net income −$3.98B, EPS −$3.13 |
| Oct 29, 20258-K | Earnings release — EPS $1.60 vs $1.36 est. (+17.6%); revenue $102.87B (+8% y/y) 1.9% |
| Sep 22, 20258-K | Other events |
| Aug 15, 20258-K | Other events |
| Jul 31, 202510-Q | Quarterly report, Q2 2025 — revenue $98.92B (+8% y/y), net income $1.02B, EPS $0.80 |
| Jul 31, 20258-K | Results of operations |
| May 20, 20258-K | Shareholder vote results |
| May 1, 202510-Q | Quarterly report, Q1 2025 — revenue $94.59B (+7% y/y), net income $1.78B, EPS $1.41 |
| May 1, 20258-K | Results of operations |
| Apr 8, 20258-K | Directors or officers; compensation; Regulation FD disclosure |
| Apr 4, 2025ARS | Annual report to shareholders |
| Apr 4, 2025DEFA14A | Additional proxy materials |
| Apr 4, 2025DEF 14A | Proxy statement |
| Feb 12, 202510-K | Annual report, FY2024 — revenue $372.81B (+4% y/y), net income $4.61B, EPS $3.66 |
| Feb 12, 20258-K | Results of operations |
2024 · 26 filings
| Filed | What it is |
|---|---|
| Dec 17, 20248-K | Other events |
| Dec 10, 20248-K | Other events |
| Dec 9, 20248-K | Other events |
| Dec 6, 20248-K | Other events |
| Dec 5, 20248-K | Other events |
| Dec 2, 20248-K | Other events |
| Nov 18, 20248-K | Material definitive agreement; Directors or officers; compensation; Regulation FD disclosure |
| Nov 6, 20248-K | Directors or officers; compensation; Regulation FD disclosure |
| Nov 6, 202410-Q | Quarterly report, Q3 2024 — revenue $95.43B (+6% y/y), net income $87.0M, EPS $0.07 |
| Nov 6, 20248-K | Results of operations |
| Oct 18, 20248-K | Results of operations; Directors or officers; compensation; Regulation FD disclosure |
| Aug 7, 202410-Q | Quarterly report, Q2 2024 — revenue $91.23B (+3% y/y), net income $1.77B, EPS $1.41 |
| Aug 7, 20248-K | Results of operations |
| May 22, 20248-K | Directors or officers; compensation; Shareholder vote results |
| May 9, 20248-K | Other events |
| May 8, 20248-K | Other events |
| May 1, 202410-Q | Quarterly report, Q1 2024 — revenue $88.44B (+4% y/y), net income $1.11B, EPS $0.88 |
| May 1, 20248-K | Results of operations |
| Apr 16, 2024PX14A6G | Shareholder exempt solicitation |
| Apr 5, 2024ARS | Annual report to shareholders |
| Apr 5, 2024DEFA14A | Additional proxy materials |
| Apr 5, 2024DEF 14A | Proxy statement |
| Mar 5, 20248-K | Regulation FD disclosure |
| Feb 7, 202410-K | Annual report, FY2023 — revenue $357.78B (+11% y/y), net income $8.34B, EPS $6.47 |
| Feb 7, 20248-K | Results of operations |
| Jan 5, 20248-K | Results of operations; Directors or officers; compensation; Regulation FD disclosure |
2023 · 37 filings — 25 × 8-K, 3 × 10-Q, 3 × DFAN14A and 5 other forms
| Filed | What it is |
|---|---|
| Nov 1, 202310-Q | Quarterly report, Q3 2023 — revenue $89.76B (+11% y/y), net income $2.26B, EPS $1.75 |
| Aug 2, 202310-Q | Quarterly report, Q2 2023 — revenue $88.92B (+10% y/y), net income $1.90B, EPS $1.48 |
| May 3, 2023PX14A6G | Shareholder exempt solicitation |
| May 3, 202310-Q | Quarterly report, Q1 2023 — revenue $85.28B (+11% y/y), net income $2.14B, EPS $1.65 |
| Apr 26, 2023PX14A6G | Shareholder exempt solicitation |
| Apr 7, 2023ARS | Annual report to shareholders |
| Apr 7, 2023DEFA14A | Additional proxy materials |
| Apr 7, 2023DEF 14A | Proxy statement |
| Mar 7, 2023DFAN14A | SOLICITING MATERIAL |
| Feb 9, 2023DFAN14A | PROXY STATEMENT PURSUANT TO SECTION 14(A) |
| Feb 8, 2023DFAN14A | PROXY STATEMENT PURSUANT TO SECTION 14(A) |
| Feb 8, 202310-K | Annual report, FY2022 — revenue $322.47B (+10% y/y), net income $4.31B, EPS $3.26 |
25 current reports (8-K) not listed; the year is on EDGAR.
2022 · 30 filings — 20 × 8-K, 3 × 10-Q, 3 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Nov 2, 202210-Q | Quarterly report, Q3 2022 — revenue $81.16B (+10% y/y), net income −$3.41B, EPS −$2.59 |
| Sep 7, 2022DEFA14A | Additional proxy materials |
| Sep 6, 2022DEFA14A | Additional proxy materials |
| Aug 3, 202210-Q | Quarterly report, Q2 2022 — revenue $80.64B (+11% y/y), net income $3.03B, EPS $2.29 |
| May 11, 2022PX14A6G | Shareholder exempt solicitation |
| May 4, 202210-Q | Quarterly report, Q1 2022 — revenue $76.83B (+11% y/y), net income $2.35B, EPS $1.77 |
| Apr 6, 2022PX14A6G | Shareholder exempt solicitation |
| Apr 1, 2022DEFA14A | Additional proxy materials |
| Apr 1, 2022DEF 14A | Proxy statement |
| Feb 9, 202210-K | Annual report, FY2021 — revenue $292.11B (+9% y/y), net income $8.00B, EPS $6.02 |
20 current reports (8-K) not listed; the year is on EDGAR.
2021 · 20 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 3, 202110-Q | Quarterly report, Q3 2021 — revenue $73.79B (+10% y/y), net income $1.60B, EPS $1.20 |
| Aug 4, 202110-Q | Quarterly report, Q2 2021 — revenue $72.62B (+11% y/y), net income $2.78B, EPS $2.10 |
| May 4, 202110-Q | Quarterly report, Q1 2021 — revenue $69.10B (+4% y/y), net income $2.22B, EPS $1.68 |
| Apr 2, 2021DEFA14A | Additional proxy materials |
| Apr 2, 2021DEF 14A | Proxy statement |
| Feb 16, 202110-K | Annual report, FY2020 — revenue $268.71B (+5% y/y), net income $7.18B, EPS $5.46 |
14 current reports (8-K) not listed; the year is on EDGAR.
2020 · 34 filings — 24 × 8-K, 5 × DEFA14A, 3 × 10-Q and 2 other forms
| Filed | What it is |
|---|---|
| Nov 6, 202010-Q | Quarterly report, Q3 2020 — revenue $67.06B (+4% y/y), net income $1.22B, EPS $0.93 |
| Aug 5, 202010-Q | Quarterly report, Q2 2020 — revenue $65.34B (+3% y/y), net income $2.98B, EPS $2.26 |
| May 6, 2020DEFA14A | Additional proxy materials |
| May 6, 202010-Q | Quarterly report, Q1 2020 — revenue $66.75B (+9% y/y), net income $2.01B, EPS $1.53 |
| Apr 24, 2020DEFA14A | Additional proxy materials |
| Apr 24, 2020DEFA14A | Additional proxy materials |
| Apr 3, 2020DEFA14A | Additional proxy materials |
| Apr 3, 2020DEFA14A | Additional proxy materials |
| Apr 3, 2020DEF 14A | Proxy statement |
| Feb 18, 202010-K | Annual report, FY2019 — revenue $256.78B (+32% y/y), net income $6.63B, EPS $5.08 |
24 current reports (8-K) not listed; the year is on EDGAR.
2019 · 23 filings — 15 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Nov 6, 201910-Q | Quarterly report, Q3 2019 — revenue $64.55B (+37% y/y), net income $1.53B, EPS $1.17 |
| Aug 7, 201910-Q | Quarterly report, Q2 2019 — revenue $63.14B (+35% y/y), net income $1.94B, EPS $1.49 |
| May 7, 2019DEFA14A | Additional proxy materials |
| May 1, 201910-Q | Quarterly report, Q1 2019 — revenue $61.40B (+34% y/y), net income $1.42B, EPS $1.09 |
| Apr 5, 2019DEFA14A | Additional proxy materials |
| Apr 5, 2019DEF 14A | Proxy statement |
| Feb 28, 201910-K | Annual report, FY2018 — revenue $193.92B (+5% y/y), net income −$594.0M, EPS −$0.57 |
16 current reports (8-K) not listed; the year is on EDGAR.
2018 · 31 filings — 24 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Nov 6, 201810-Q | Quarterly report, Q3 2018 — revenue $47.27B (+2% y/y), net income $1.39B, EPS $1.36 |
| Aug 8, 201810-Q | Quarterly report, Q2 2018 — revenue $46.71B (+2% y/y), net income −$2.56B, EPS −$2.52 |
| May 2, 201810-Q | Quarterly report, Q1 2018 — revenue $45.69B (+3% y/y), net income $998.0M, EPS $0.98 |
| Apr 24, 2018DEFA14A | Additional proxy materials |
| Apr 24, 2018DEF 14A | Proxy statement |
| Apr 12, 2018PRE 14A | Preliminary proxy statement |
| Feb 14, 201810-K | Annual report, FY2017 — revenue $184.76B (+4% y/y), net income $6.62B, EPS $6.44 |
24 current reports (8-K) not listed; the year is on EDGAR.
2017 · 17 filings — 9 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Nov 6, 201710-Q | Quarterly report, Q3 2017 — revenue $46.19B (+4% y/y), net income $1.28B, EPS $1.26 |
| Aug 8, 201710-Q | Quarterly report, Q2 2017 — revenue $45.69B (+4% y/y), net income $1.10B, EPS $1.07 |
| May 3, 2017PX14A6G | Shareholder exempt solicitation |
| May 2, 201710-Q | Quarterly report, Q1 2017 — revenue $44.52B (+3% y/y), net income $952.0M, EPS $0.92 |
| May 1, 2017DEFA14A | Additional proxy materials |
| Mar 31, 2017DEFA14A | Additional proxy materials |
| Mar 31, 2017DEF 14A | Proxy statement |
| Feb 9, 201710-K | Annual report, FY2016 — revenue $177.53B (+16% y/y), net income $5.32B, EPS $4.90 |
9 current reports (8-K) not listed; the year is on EDGAR.
2016 · 22 filings — 13 × 8-K, 3 × 10-Q, 2 × 8-K/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2015 · 27 filings — 16 × 8-K, 3 × 10-Q, 3 × DEFA14A and 4 other forms
Counted, not listed; the year is on EDGAR.
2014 · 20 filings — 13 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms
Counted, not listed; the year is on EDGAR.
2013 · 23 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2012 · 21 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2011 · 25 filings — 16 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
Counted, not listed; the year is on EDGAR.
2010 · 16 filings — 8 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
Counted, not listed; the year is on EDGAR.
2009 · 17 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2008 · 18 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2007 · 31 filings — 22 × 8-K, 3 × 10-Q, 1 × 10-K and 5 other forms
Counted, not listed; the year is on EDGAR.
2006 · 23 filings — 16 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2005 · 17 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2004 · 18 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2003 · 9 filings — 4 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2002 · 9 filings — 4 × 8-K, 3 × 10-Q, 1 × 10-K405 and 1 other form
Counted, not listed; the year is on EDGAR.
2001 · 7 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2000 · 8 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
1999 · 13 filings — 4 × 8-K, 3 × 10-Q, 3 × 10-Q/A and 3 other forms
Counted, not listed; the year is on EDGAR.
1998 · 11 filings — 5 × 8-K, 3 × 10-Q, 1 × 10-K405 and 2 other forms
Counted, not listed; the year is on EDGAR.
1997 · 13 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K405 and 3 other forms
Counted, not listed; the year is on EDGAR.
1996 · 11 filings — 5 × 8-K, 3 × 10-Q, 2 × DEF 14A and 1 other form
Counted, not listed; the year is on EDGAR.
1995 · 7 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
1994 · 5 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 45 filings — 32 × 4, 3 × 13F-HR, 3 × 144 and 6 other forms
| Filed | What it is |
|---|---|
| Aug 13, 2026SCHEDULE 13G/A | Other filings |
| Aug 6, 202613F-HR | Other filings |
| Jun 29, 20264 | Insider transaction (Form 4) |
| Jun 23, 202611-K | Employee plan annual report |
| Jun 1, 20264 | Insider transaction (Form 4) |
| Jun 1, 20264 | Insider transaction (Form 4) |
| May 22, 20264 | Insider transaction (Form 4) |
| May 22, 2026144 | Notice of proposed sale (Form 144) |
| May 22, 2026S-8 | Employee stock plan registration |
| May 22, 2026S-3ASR | Automatic shelf registration |
| May 21, 20264 | Insider transaction (Form 4) |
| May 21, 2026144 | Notice of proposed sale (Form 144) |
| May 15, 20264 | Insider transaction (Form 4) |
| May 15, 20264 | Insider transaction (Form 4) |
| May 15, 20264 | Insider transaction (Form 4) |
| May 15, 20264 | Insider transaction (Form 4) |
| May 15, 20264 | Insider transaction (Form 4) |
| May 15, 20264 | Insider transaction (Form 4) |
| May 15, 20264 | Insider transaction (Form 4) |
| May 15, 20264 | Insider transaction (Form 4) |
| May 15, 20264 | Insider transaction (Form 4) |
| May 15, 20264 | Insider transaction (Form 4) |
| May 15, 20264 | Insider transaction (Form 4) |
| May 15, 20264 | Insider transaction (Form 4) |
| May 11, 20264 | Insider transaction (Form 4) |
The newest 25 of 45 shown; the full year is on EDGAR.
2025 · 67 filings — 49 × 4, 4 × 13F-HR, 2 × 144 and 9 other forms
| Filed | What it is |
|---|---|
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 7, 20253/A | Initial insider holdings (Form 3), amended |
| Oct 31, 202513F-HR | Other filings |
| Oct 14, 20254 | Insider transaction (Form 4) |
| Oct 14, 20253/A | Initial insider holdings (Form 3), amended |
| Sep 2, 20254 | Insider transaction (Form 4) |
| Sep 2, 20254 | Insider transaction (Form 4) |
| Aug 29, 20254 | Insider transaction (Form 4) |
| Aug 19, 2025144 | Notice of proposed sale (Form 144) |
| Aug 12, 2025424B2 | Prospectus supplement |
| Aug 12, 2025FWP | Free writing prospectus |
The newest 25 of 67 shown; the full year is on EDGAR.
2024 · 85 filings — 58 × 4, 6 × 3, 4 × 13F-HR and 11 other forms
| Filed | What it is |
|---|---|
| Dec 26, 20244/A | Insider transaction (Form 4), amended |
| Dec 9, 20244 | Insider transaction (Form 4) |
| Dec 5, 2024424B2 | Prospectus supplement |
| Dec 4, 2024FWP | Free writing prospectus |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 2024424B3 | Prospectus |
| Nov 25, 20244 | Insider transaction (Form 4) |
| Nov 25, 20244 | Insider transaction (Form 4) |
| Nov 25, 20244 | Insider transaction (Form 4) |
| Nov 25, 20244 | Insider transaction (Form 4) |
| Nov 25, 20243 | Initial insider holdings (Form 3) |
| Nov 25, 20244 | Insider transaction (Form 4) |
| Nov 25, 20243 | Initial insider holdings (Form 3) |
| Nov 25, 20243 | Initial insider holdings (Form 3) |
| Nov 25, 20243 | Initial insider holdings (Form 3) |
| Nov 25, 20244 | Insider transaction (Form 4) |
| Nov 25, 20244 | Insider transaction (Form 4) |
| Nov 25, 20244 | Insider transaction (Form 4) |
| Nov 25, 20244 | Insider transaction (Form 4) |
The newest 25 of 85 shown; the full year is on EDGAR.
2023 · 80 filings — 53 × 4, 6 × 3, 4 × 13F-HR and 10 other forms
Counted, not listed; the year is on EDGAR.
2022 · 84 filings — 68 × 4, 5 × 3, 4 × 13F-HR and 4 other forms
Counted, not listed; the year is on EDGAR.
2021 · 80 filings — 71 × 4, 3 × 3, 2 × SC 13G/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2020 · 93 filings — 65 × 4, 10 × 4/A, 3 × 424B2 and 8 other forms
Counted, not listed; the year is on EDGAR.
2019 · 86 filings — 69 × 4, 3 × CORRESP, 3 × UPLOAD and 8 other forms
Counted, not listed; the year is on EDGAR.
2018 · 142 filings — 54 × 4, 52 × 425, 10 × 3 and 14 other forms
Counted, not listed; the year is on EDGAR.
2017 · 127 filings — 66 × 4, 43 × 425, 4 × CORRESP and 9 other forms
Counted, not listed; the year is on EDGAR.
2016 · 77 filings — 57 × 4, 6 × NO ACT, 3 × SC 13G/A and 9 other forms
Counted, not listed; the year is on EDGAR.
2015 · 87 filings — 61 × 4, 3 × 3, 3 × CORRESP and 14 other forms
Counted, not listed; the year is on EDGAR.
2014 · 66 filings — 53 × 4, 3 × NO ACT, 2 × UPLOAD and 8 other forms
Counted, not listed; the year is on EDGAR.
2013 · 77 filings — 62 × 4, 3 × 3, 2 × 5 and 9 other forms
Counted, not listed; the year is on EDGAR.
2012 · 96 filings — 78 × 4, 3 × UPLOAD, 2 × 3 and 9 other forms
Counted, not listed; the year is on EDGAR.
2011 · 85 filings — 64 × 4, 5 × 3, 3 × 5 and 10 other forms
Counted, not listed; the year is on EDGAR.
2010 · 80 filings — 61 × 4, 5 × NO ACT, 4 × 3 and 8 other forms
Counted, not listed; the year is on EDGAR.
2009 · 76 filings — 65 × 4, 2 × 424B2, 2 × 424B3 and 5 other forms
Counted, not listed; the year is on EDGAR.
2008 · 97 filings — 73 × 4, 4 × 3, 4 × NO ACT and 10 other forms
Counted, not listed; the year is on EDGAR.
2007 · 239 filings — 154 × 4, 32 × 425, 10 × 3 and 19 other forms
Counted, not listed; the year is on EDGAR.
2006 · 139 filings — 113 × 4, 8 × 425, 4 × UPLOAD and 11 other forms
Counted, not listed; the year is on EDGAR.
2005 · 115 filings — 109 × 4, 2 × NO ACT, 2 × SC 13G/A and 2 other forms
Counted, not listed; the year is on EDGAR.
2004 · 78 filings — 58 × 4, 7 × 5, 2 × CORRESP and 10 other forms
Counted, not listed; the year is on EDGAR.
2003 · 74 filings — 46 × 4, 21 × 5, 3 × SC 13G/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2002 · 6 filings — 3 × SC 13G/A, 1 × 11-K, 1 × 4 and 1 other form
Counted, not listed; the year is on EDGAR.
2001 · 9 filings — 2 × SC 13G, 2 × SC 13G/A, 1 × 11-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2000 · 4 filings — 4 × SC 13G/A
Counted, not listed; the year is on EDGAR.
1999 · 8 filings — 3 × S-4/A, 2 × SC 13G/A, 1 × S-4 and 2 other forms
Counted, not listed; the year is on EDGAR.
1998 · 10 filings — 2 × S-3/A, 1 × 424B1, 1 × S-3 and 6 other forms
Counted, not listed; the year is on EDGAR.
1997 · 19 filings — 5 × S-8 POS, 2 × 424B4, 2 × S-8 and 8 other forms
Counted, not listed; the year is on EDGAR.
1996 · 10 filings — 3 × SC 13G, 3 × SC 13G/A, 1 × 8-B12B and 3 other forms
Counted, not listed; the year is on EDGAR.
1995 · 7 filings — 7 × SC 13G/A
Counted, not listed; the year is on EDGAR.
1994 · 2 filings — 2 × SC 13G/A
Counted, not listed; the year is on EDGAR.
About this data#
CVS Health Corporation (CVS) has 2,968 filings on EDGAR going back to 1994: 35 annual reports, 102 quarterly reports and 391 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 10, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Aug 17, 2026, furnished a press release headed “CVS Health Announces Board Changes”. Over the last 13 months insiders sold $359.0M in 5 sales and bought $1,289 in 1 purchase; 45 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been CVS Health Corporation, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read CVS's latest 10-K?
- CVS's latest annual report, a 10-K, was filed on Feb 10, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did CVS last file an 8-K?
- On Aug 17, 2026 it furnished a press release headed “CVS Health Announces Board Changes”. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 5, 2026.
- Are CVS insiders buying or selling?
- Over the last 13 months insiders sold $359.0M in 5 sales and bought $1,289 in 1 purchase; 45 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: ROBBINS LARRY (Director) sold 378,000 shares on May 21, 2026 for $35.3M. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has CVS made?
- 2,968 filings are on EDGAR under the registrant records that have been CVS Health Corporation, going back to 1994; 1,807 of them are insider ownership forms (Forms 3, 4, 5 and 144).